Sort
53,477 grants matching “addiction”
Researching Effective Strategies to Prevent Opioid Death (RESPOND)
$716,684Benjamin P Linas · Boston Medical Center · R01 · FY2020 · DA
Pharmacologically-based Strategies for Buprenorphine Treatment During Pregnancy
$716,681Steve N Caritis · Magee-Women'S Res Inst And Foundation · R01 · FY2018 · HD
Gabapentin Treatment of Cannabis Dependence
$716,618Barbara J Mason · Scripps Research Institute, The · R01 · FY2011 · DA
Data Driven Strategies for Substance Misuse Identification in Hospitalized Patients
$716,603Majid Afshar · University Of Wisconsin-Madison · R01 · FY2023 · DA
Enhancing Infrastructure for Clinical and Translational Research to Address the Opioid Epidemic
$716,466Leslie A Lenert · Medical University Of South Carolina · U01 · FY2022 · TR
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse
$716,442Joan Weinberger Berman · Albert Einstein College Of Medicine · R01 · FY2021 · DA
Collaborative Care for Primary Care Patients with Alcohol Use Disorders
$716,432Katharine Anthony Bradley · Kaiser Foundation Health Plan Of Washington · R01 · FY2012 · AA
Imaging sex differences in smoking-induced dopamine release via novel PET methods
$716,421Evan D Morris · Yale University · R01 · FY2020 · DA
Epigenetic involvement in socio-emotional behavior studied by PET- MRI
$716,409Nicole R Zurcher Wimmer · Massachusetts General Hospital · R01 · FY2023 · MH
Epigenetic involvement in socio-emotional behavior studied by PET- MRI
$716,409Nicole R Zurcher Wimmer · Massachusetts General Hospital · R01 · FY2024 · MH
Neurotensin receptor 1 as a novel target for opioid use disorder and discovery of new small molecule probes
$716,226Lauren M Slosky · University Of Minnesota · R01 · FY2024 · DA
Research Project 2 : Sweet and Cooling Flavors and Nicotine: Examinations in New and Established Tobacco Product Users
$716,165Suchitra Krishnan-Sarin · Yale University · U54 · FY2021 · DA
Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)
$716,104Mark P. McGovern · Stanford University · R01 · FY2021 · DA
Repeated-dose behavioral intervention to reduce opioid overdose: a two-site randomized-controlled efficacy trial
$716,100Phillip O Coffin · Public Health Foundation Enterprises · R01 · FY2018 · DA
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$716,028Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2019 · DA
A Novel Workflow to Screen for Illicit Drug Exposure in Newborns
$716,018Rainer Ng · Baebies, Inc. · R44 · FY2020 · DA
Opioid Overdoses among Medicaid Beneficiaries: Predictors, Outcomes, and State Policy Effects
$716,003Stephen Crystal · Rutgers, The State Univ Of N.J. · R01 · FY2019 · DA
Assessing the Clinical and Cost-Effectiveness of a Virtual PEth-based Contingency Management for Adults with AUD
$715,994Michael G McDonell · Washington State University · R01 · FY2023 · AA
Regulation of Craving: Clinical Trial and Neural Mechanisms
$715,925Hedy Kober · Yale University · R01 · FY2022 · AA
Studying How State and Local Health Services Delivery Policies can Mitigate the Effects of Disasters on Drug Addiction Treatment and Overdose: A Mixed-Methods Study of COVID-19.
$715,845Matthew Eisenberg · Johns Hopkins University · R01 · FY2022 · DA
Advancing Communication Science to Reduce Disparities in Young Adult Cigar Use
$715,786Adam O Goldstein · Univ Of North Carolina Chapel Hill · U54 · FY2023 · DA
Contributions of aberrant synaptic protein monoaminylation to opiate use disorder
$715,783Ian S. Maze · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · DA
Provision of Drug Abuse Treatment Services Under Parity
$715,772Constance M Horgan · Brandeis University · R01 · FY2012 · DA
Component 2: Administrative Core
$715,758Robert O. Messing · Ernest Gallo Clinic And Research Center · P50 · FY2009 · AA
Non-opiate topical formulations for treating pain associated with molar extractions
$715,640Alan Parr · Arcato Laboratories, Inc. · R44 · FY2022 · DE